Cargando…

Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma

MYSM1 is a chromatin‐binding protein, widely investigated for its functions in haematopoiesis in human and mouse; however, its role in haematologic malignancies remains unexplored. Here, we investigate the cross‐talk between MYSM1 and oncogenic cMYC in the transcriptional regulation of genes encodin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yun Hsiao, Wang, HanChen, Fiore, Amanda, Förster, Michael, Tung, Lin Tze, Belle, Jad I, Robert, Francis, Pelletier, Jerry, Langlais, David, Nijnik, Anastasia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278115/ https://www.ncbi.nlm.nih.gov/pubmed/34114734 http://dx.doi.org/10.1111/jcmm.16554

Ejemplares similares

Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review
por: Fiore, Amanda, et al.
Publicado: (2020)

p53-dependent induction of P2X7 on hematopoietic stem and progenitor cells regulates hematopoietic response to genotoxic stress
por: Tung, Lin Tze, et al.
Publicado: (2021)

Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development
por: Liang, Yue, et al.
Publicado: (2023)

Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance
por: Belle, J I, et al.
Publicado: (2016)

Regulation of B Lymphocyte Development by Histone H2A Deubiquitinase BAP1
por: Lin, Yun Hsiao, et al.
Publicado: (2021)

AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development
por: Takizawa, Makiko, et al.
Publicado: (2008)

A proteomic study of cMyc improvement of CHO culture
por: Kuystermans, Darrin, et al.
Publicado: (2010)

Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts
por: Heffernan, Corey, et al.
Publicado: (2012)

Transformation of normal cells by aberrant activation of YAP via cMyc with TEAD
por: Nishimoto, Masazumi, et al.
Publicado: (2019)

Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8
por: Anderson, David A., et al.
Publicado: (2021)

cMyc/miR-125b-5p Signalling Determines Sensitivity to Bortezomib in Preclinical Model of Cutaneous T-Cell Lymphomas
por: Manfè, Valentina, et al.
Publicado: (2013)

Convergence of cMyc and β‐catenin on Tcf7l1 enables endoderm specification
por: Morrison, Gillian, et al.
Publicado: (2015)

SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of cMYC oncoprotein
por: Geng, Chuandong, et al.
Publicado: (2017)

cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis
por: Sakr, Hany I., et al.
Publicado: (2017)

Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer
por: Zhu, Hongwen, et al.
Publicado: (2023)

A forward genetic screen identifies modifiers of rocaglate responsiveness
por: Shen, Leo, et al.
Publicado: (2021)

Glutathione Metabolism Is a Regulator of the Acute Inflammatory Response of Monocytes to (1→3)-β-D-Glucan
por: Ramendra, Rayoun, et al.
Publicado: (2021)

Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
por: Loftus, Róisín M., et al.
Publicado: (2018)

PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis
por: Qin, Yi, et al.
Publicado: (2019)

The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
por: Xu, Lei, et al.
Publicado: (2019)

Concomitant Classic Hodgkin Lymphoma of Lymph Node and cMYC-Positive Burkitt Leukemia/Lymphoma of the Bone Marrow Presented Concurrently at the Time of Presentation: A Rare Combination of Discordant Lymphomas
por: Soliman, Dina S., et al.
Publicado: (2016)

Association of CMYC polymorphisms with hepatoblastoma risk
por: Yang, Tianyou, et al.
Publicado: (2020)

Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis
por: Figueiredo, Jane C, et al.
Publicado: (2007)

cMyc increases cell number through uncoupling of cell division from cell size in CHO cells
por: Kuystermans, Darrin, et al.
Publicado: (2009)

The Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc()()
por: Prensner, John R., et al.
Publicado: (2014)

Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc
por: Luo, Haitao, et al.
Publicado: (2010)

MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN
por: Chen, Pan, et al.
Publicado: (2016)

TRIM66 Overexpression Promotes Glioma Progression and Regulates Glucose Uptake Through cMyc/GLUT3 Signaling
por: Song, Yuequn, et al.
Publicado: (2021)

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
por: Nyquist, Michael D., et al.
Publicado: (2023)

Sequence-to-expression approach to identify etiological non-coding DNA variations in P53 and cMYC-driven diseases
por: Kin, Katherine, et al.
Publicado: (2023)

Expression of MYSM1 is associated with tumor progression in colorectal cancer
por: Li, Yongmin, et al.
Publicado: (2017)

MYSM1 Is Essential for Maintaining Hematopoietic Stem Cell (HSC) Quiescence and Survival
por: Huo, Yi, et al.
Publicado: (2018)

Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming
por: Simula, Luca, et al.
Publicado: (2018)

Correction: Expression of MYSM1 is associated with tumor progression in colorectal cancer
por: Li, Yongmin, et al.
Publicado: (2017)

MYSM1 Suppresses Cellular Senescence and the Aging Process to Prolong Lifespan
por: Tian, Mingfu, et al.
Publicado: (2020)

Developments in Burkitt’s lymphoma: novel cooperations in oncogenic MYC signaling
por: Spender, Lindsay C, et al.
Publicado: (2014)

RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
por: George, Jasmine, et al.
Publicado: (2021)

Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma
por: Jiang, Houxiang, et al.
Publicado: (2023)

Deubiquitinase MYSM1 Is Essential for Normal Bone Formation and Mesenchymal Stem Cell Differentiation
por: Li, Ping, et al.
Publicado: (2016)

Ubiquitin Specific Protease 21 Is Dispensable for Normal Development, Hematopoiesis and Lymphocyte Differentiation
por: Pannu, Jaspreet, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_clk51jmj77lcnp8rptehch1d89